Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeted cancer therapies. Its boronic acid functional group enables Suzuki-Miyaura cross-coupling reactions, facilitating the construction of complex biaryl structures found in bioactive molecules. Commonly employed in the development of tyrosine kinase and BTK inhibitors due to its ability to enhance binding affinity and selectivity. Also utilized in medicinal chemistry for optimizing pharmacokinetic properties such as metabolic stability and membrane permeability.